Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,153,414 papers from all fields of science
Search
Sign In
Create Free Account
NSC 363812
Known as:
NSC-363812
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
ormaplatin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812)
K. Tutsch
,
R. Arzoomanian
,
+5 authors
G. Wilding
Investigational new drugs
2004
Corpus ID: 7451665
Ormaplatin (NSC 363812, tetraplatin) is a stable platinum (IV) analog which has exhibited activity against cisplatin-resistant…
Expand
Highly Cited
1994
Highly Cited
1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
R. Schilder
,
F. LaCreta
,
+7 authors
D. Roby
Cancer Research
1994
Corpus ID: 14004621
Ormaplatin (tetraplatin, NSC 363812) is a platinum(IV) analogue that is active against cisplatin-resistant cell lines in…
Expand
1994
1994
Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812)
T. O'rourke
,
G. Weiss
,
+8 authors
D. V. Von Hoff
Anti-Cancer Drugs
1994
Corpus ID: 45535824
Ormaplatin Is a platinum analog that was developed because of an altered toxlclty profile and non-cross resistance to clsplatln…
Expand
Highly Cited
1988
Highly Cited
1988
Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.
J. H. Smith
,
M. Smith
,
C. Litterst
,
M. Copley
,
J. Uozumi
,
M. Boyd
Fundamental and Applied Toxicology
1988
Corpus ID: 21156473
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE